Implantable Cardioverter Defibrillator (ICD) Registry to Track Patient Outcomes and Device Use

What this Trial Is About

The ICD Registry is a nationwide program designed to help hospitals track and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillators (CRT-Ds). It collects detailed data on patient characteristics, treatments, and outcomes to ensure appropriate use of these devices, especially following expanded coverage indications by Medicare for primary prevention. This registry was established in response to a mandate by the Centers for Medicare and Medicaid Services (CMS) to monitor ICD use in Medicare patients after important clinical trial findings. The registry collects patient-level data from participating hospitals quarterly, which is submitted to the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). This data includes patients receiving ICDs or CRT-Ds for both primary and secondary prevention, including initial implants, generator changes, and lead-only procedures. The NCDR then produces an Outcomes Report comparing each hospital's data to peer groups and the overall registry dataset. Participants in the registry have their post-procedure complications and death rates tracked from the time of device implantation until hospital discharge, with reports generated quarterly based on rolling yearly data. The registry continuously monitors outcomes to support quality improvement in ICD and CRT-D care. Enrollment began in June 2005, and the program continues to collect data to enhance patient safety and treatment effectiveness over time.

Implantable Cardioverter Defibrillator (ICD Registry)